CRYO Cryo-Save

 

TIDMCRYO 
 
RNS Number : 4504Y 
Cryo-Save Group NV 
03 September 2009 
 

3 September 2009 
Cryo-Save Group NV 
 
 
Cryo-Save plans to list on Euronext 
 
 
Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save"), Europe's leading stem cell 
bank, plans to seek an additional listing on Euronext Amsterdam in the fourth 
quarter of the current financial year to complement the Group's shares being 
traded on AIM in London.  Cryo-Save was admitted to trading on AIM on 6 November 
2007. 
 
 
Cryo-Save intends to review the need to maintain the AIM listing early 
2010. Cryo-Save expects to make further announcements with regards to the 
Euronext listing in due course. 
 
 
Marc Waeterschoot, Chief Executive, commented: 
 
 
"We are looking to become listed on Euronext in Amsterdam. Being a Dutch 
company, with most of our business on the continent, a local listing should 
increase our visibility as well as liquidity." 
 
 
 
 
+-------------------------------------+----------------------------------+ 
| For further details:                |                                  | 
+-------------------------------------+----------------------------------+ 
|                                     |                                  | 
+-------------------------------------+----------------------------------+ 
| Cryo-Save Group                     |             + 31 (0) 575 548998  | 
+-------------------------------------+----------------------------------+ 
| Marc Waeterschoot, Chief Executive  |                                  | 
+-------------------------------------+----------------------------------+ 
| Arnoud van Tulder, Chief Financial  |                                  | 
| Officer                             |                                  | 
+-------------------------------------+----------------------------------+ 
|                                     |                                  | 
+-------------------------------------+----------------------------------+ 
| Daniel Stewart & Company plc        |           + 44 (0) 20 7776 6550  | 
+-------------------------------------+----------------------------------+ 
| Simon Leathers/Charlotte Stranner   |                                  | 
+-------------------------------------+----------------------------------+ 
|                                     |                                  | 
+-------------------------------------+----------------------------------+ 
| College Hill                        |           + 44 (0) 20 7457 2020  | 
+-------------------------------------+----------------------------------+ 
| Adrian Duffield/Rozi Morris         |                                  | 
+-------------------------------------+----------------------------------+ 
 
 
About Cryo-Save 
 
 
With more than 100,000 samples saved, Cryo-Save is the leading stem cell bank in 
Europe and one of the fastest growing in the world. Driven by its international 
business strategy, Cryo-Save is now represented in 38 countries on three 
continents and has state-of-the-art processing facilities in Belgium, Germany, 
Dubai, India and France (under construction). 
 
 
Cryo-Save sets the highest quality standards in stem cell storage, as it aims to 
make an important contribution to conquer possible life-threatening diseases in 
the future. As a service to the public, Cryo-Save offers a Cost-free Family 
Donation Programme, free of charge, to families wishing to store their newborn's 
umbilical cord blood stem cells for a family member diagnosed with a 
life-threatening disease treatable by stem cells. The company is committed to 
further improve stem cell cryopreservation techniques, by participating in 
European Commission funded projects, in Universities and Hospitals. 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCSSWSMDSUSEEU 
 

Grafico Azioni Cryo-Save (LSE:CRYO)
Storico
Da Dic 2024 a Gen 2025

Grafico Azioni Cryo-Save (LSE:CRYO)
Storico
Da Gen 2024 a Gen 2025